Polysaccharides and Inflammation
Several chronic diseases such as Type 2 diabetes, metabolic syndrome and cardiovascular diseases have been shown to be associated with inflammation attributable to increases in TNF-α, IL-6 and C-reactive proteins, in addition to others. Furthermore, evidence strongly supports a link between inflammatory bowel disease (IBD) and various medical indications.
It has been shown that pectin, a plant-derived carbohydrate, has a favorable effect on a broad range of pathological conditions. In IBD, pectin may aid in decreasing the inflammatory response in the colon by moderating the amounts of pro-inflammatory cytokines and immunoglobulins, and may work to reduce inflammation in a dose-dependent manner.
Our proprietary carbohydrate new chemical structure called BTI-9 is a patented, polysaccharide which has been shown to bind to TNF-α and thereby block immune system activation and inflammation. We expect BTI-9 to be available in late 2016 as a dietary supplement to support colon health.